Orchid Pharma gets EIR report from USFDA on inspection closure for Tamil Nadu plant

Orchid Pharma Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 524372 | NSE: ORCHPHARMA

11 Apr 2016 Evaluate

Orchid Pharma has received the Establishment inspection report (EIR) from US Food and Drug Administration (USFDA) based on the successful inspection closure for the API manufacturing facility located at Alathur in Kancheepuram District, Tamil Nadu. The facility was inspected by USFDA in the month of August 2015.

Orchid Pharma is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs.

Peers

Company Name	CMP
Sun Pharma. Inds.	1852.50
Dr. Reddys Labs.	1146.30
Cipla	1360.10
Lupin	2047.00
Zydus Lifesciences	1108.50
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.